BI 1584862 / Boehringer Ingelheim - LARVOL DELTA

A Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems (clinicaltrials.gov) - P1 | N=44 | Recruiting | Sponsor: Boehringer Ingelheim | Not yet recruiting ➔ Recruiting

Enrollment open • Hepatitis C • Hepatology • Liver Failure

A Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems (clinicaltrials.gov) - P1 | N=44 | Not yet recruiting | Sponsor: Boehringer Ingelheim | N=32 ➔ 44

Enrollment change • Hepatitis C • Hepatology • Liver Failure

A Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems (clinicaltrials.gov) - P1 | N=32 | Not yet recruiting | Sponsor: Boehringer Ingelheim

New P1 trial • Hepatitis C • Hepatology • Liver Failure

A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy (clinicaltrials.gov) - P2 | N=138 | Recruiting | Sponsor: Boehringer Ingelheim | Not yet recruiting ➔ Recruiting

Enrollment open • Age-related Macular Degeneration • Dry Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders

A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy (clinicaltrials.gov) - P2 | N=138 | Not yet recruiting | Sponsor: Boehringer Ingelheim

New P2 trial • Age-related Macular Degeneration • Dry Age-related Macular Degeneration • Macular Degeneration • Ophthalmology • Retinal Disorders

A Study in Healthy Men to Test How Well Different Doses of BI 1584862 Are Tolerated (clinicaltrials.gov) - P1 | N=32 | Completed | Sponsor: Boehringer Ingelheim | Recruiting ➔ Completed

Trial completion

A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy Men (clinicaltrials.gov) - P1 | N=50 | Completed | Sponsor: Boehringer Ingelheim | Active, not recruiting ➔ Completed

Trial completion

A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy Men (clinicaltrials.gov) - P1 | N=50 | Active, not recruiting | Sponsor: Boehringer Ingelheim | Recruiting ➔ Active, not recruiting

Enrollment closed

A Study in Healthy Men to Test How Well Different Doses of BI 1584862 Are Tolerated (clinicaltrials.gov) - P1 | N=32 | Recruiting | Sponsor: Boehringer Ingelheim | Not yet recruiting ➔ Recruiting

Enrollment open